SynthesisMedicine2017

TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.

Yucheng Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.